Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA decides future of pimagedine trials

March 26, 1998

New treatments for preterm labor from Merck

March 26, 1998

Vacuolar ATPase inhibitors claimed by SmithKline Beecham for osteoporosis

March 26, 1998

Sumitomo scientists describe new agents for hyperlipidemia

March 26, 1998

Gene therapy for treating growth hormone deficiencies

March 25, 1998

UPMC studies feasibility of gene therapy for osteoporosis

March 25, 1998

Novel treatment for red blood cell disorders available for licensing

March 25, 1998

NIH will license out new technology for studying bone metabolism

March 25, 1998

ST-630 successfully completes phase Ia trial for osteoporosis

March 25, 1998

Pyridorin looks promising for diabetic complications in preclinical models

March 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...